It has recently been shown that specific proteins in mammalian cells are modified by the covalent attachment of prenyl groups to a cysteine residue at the C-terminus via a thioether linkage. Some proteins, such as lamin B, contain a 15-carbon farnesyl group. The majority of the prenylated proteins, including the gamma-subunit of brain G-proteins, contain a 20-carbon geranylgeranyl group. We plan to continue our studies in the area of protein prenylation by focusing on three areas. Since my laboratory discovered the geranylgeranylation of proteins, a logical next step will be to purify and characterize the enzyme(s) involved in transferring the prenyl group to the cysteine residue. The substrate specificity of the prenyl transferase will be examined in order to determine the specificity rules for the geranylgeranylation versus farnesylation of proteins. The prenylation occurs on a cysteine residue that is four amino acids in from the C-terminus of the immature proteins. The last three amino acids are removed so that the prenylated cysteine is now the C-terminal residue. We plan to purify and characterize the protease(s) involved in the C-terminal hydrolysis of prenylated proteins. We also plan to develop a general synthetic strategy for the preparation of lipidated peptides. We plan to synthesize a C-terminal peptide derived from human ras proteins that is both farnesylated and palmitoylated and to use this peptide o study the membrane-binding properties to synthetic phopholipid vesicles. Both the membrane affinity and intermembrane exchanges rate will be determined by using fluorescence resonance energy transfer. This synthetic peptide will also be radio-iodinated for use in the search for specific cell- membranes receptors that bind to prenylated proteins. Similar studies will be carried out with lipidated peptides derived from farnesylated, but non-palmitoylated, forms of ras proteins and from the gamma-subunit of G-proteins. Finally, we will prepare analogs of the yeast a-factor. This phermone has been recently shown to contain a farnesyl group and we will explore the role of the prenyl group in the recognition by the yeast a-factor receptor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA052874-01A1
Application #
3197716
Study Section
Bio-Organic and Natural Products Chemistry Study Section (BNP)
Project Start
1991-04-20
Project End
1994-03-31
Budget Start
1991-04-20
Budget End
1992-03-31
Support Year
1
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of Washington
Department
Type
Schools of Arts and Sciences
DUNS #
135646524
City
Seattle
State
WA
Country
United States
Zip Code
98195
Mouchlis, Varnavas D; Magrioti, Victoria; Barbayianni, Efrosini et al. (2011) Inhibition of secreted phospholipases A? by 2-oxoamides based on ?-amino acids: Synthesis, in vitro evaluation and molecular docking calculations. Bioorg Med Chem 19:735-43
Engelson, Erin J; Buckner, Frederick S; Van Voorhis, Wesley C (2011) An essential farnesylated kinesin in Trypanosoma brucei. PLoS One 6:e26508
Chennamaneni, Naveen Kumar; Arif, Jenifer; Buckner, Frederick S et al. (2009) Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents. Bioorg Med Chem Lett 19:6582-4
Torres-Santos, Eduardo Caio; Sampaio-Santos, Maria Isabel; Buckner, Frederick S et al. (2009) Altered sterol profile induced in Leishmania amazonensis by a natural dihydroxymethoxylated chalcone. J Antimicrob Chemother 63:469-72
Gelb, Michael H (2007) Drug discovery for malaria: a very challenging and timely endeavor. Curr Opin Chem Biol 11:440-5
Ohkanda, Junko; Buckner, Frederick S; Lockman, Jeffrey W et al. (2004) Design and synthesis of peptidomimetic protein farnesyltransferase inhibitors as anti-Trypanosoma brucei agents. J Med Chem 47:432-45
Buckner, Frederick; Yokoyama, Kohei; Lockman, Jeffrey et al. (2003) A class of sterol 14-demethylase inhibitors as anti-Trypanosoma cruzi agents. Proc Natl Acad Sci U S A 100:15149-53
Gelb, Michael H; Van Voorhis, Wesley C; Buckner, Frederick S et al. (2003) Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics. Mol Biochem Parasitol 126:155-63
Buckner, Frederick S; Kateete, David P; Lubega, George W et al. (2002) Trypanosoma brucei prenylated-protein carboxyl methyltransferase prefers farnesylated substrates. Biochem J 367:809-16
Buckner, Frederick S; Eastman, Richard T; Nepomuceno-Silva, Jose L et al. (2002) Cloning, heterologous expression, and substrate specificities of protein farnesyltransferases from Trypanosoma cruzi and Leishmania major. Mol Biochem Parasitol 122:181-8

Showing the most recent 10 out of 35 publications